Azioni Aerie Pharmaceuticals, Inc.
Azioni
AERI
US00771V1089
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21/11/22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21/11/22 |
Chairman | 57 | 21/11/22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21/11/22 |
Nome | Peso | AuM | Variaz. 1 gen. | Rating Invest. |
---|---|---|---|---|
0.02% | 509 M€ | -.--% |
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,61% | 660 Mrd | |
+24,15% | 562 Mrd | |
-5,24% | 358 Mrd | |
+16,49% | 322 Mrd | |
+8,28% | 297 Mrd | |
+12,66% | 219 Mrd | |
-9,73% | 196 Mrd | |
+6,52% | 199 Mrd | |
-8,75% | 149 Mrd |